Product Information
CHLORDIAZEPOXIDE-CLIDINIUM CAP is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.2545 per EA under NDC 60219167701. Its NADAC has been published 231 times since Mar 23, 2022.
FDA first approved this application on Oct 25, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 2.5 mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
60219167701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215555FDA Approved
10/25/2021
TE Code
AB
On Market Since
10/25/2021
Pharmacological Classes
Price Statistics
The NADAC for CHLORDIAZEPOXIDE-CLIDINIUM CAP has been published 231 times since Mar 23, 2022, and over the history we have for it it has declined 73.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2545 per EA |
|---|---|
| All-time high | $0.9594 (Apr 13, 2022) |
| All-time low | $0.2088 (Apr 19, 2023) |
| 52-week high | $0.3051 |
| 52-week low | $0.2405 |
| Median price | $0.3254 |
| Average price | $0.3739 |
| Largest weekly change | +88.8% (May 17, 2023) |
| Weeks tracked | 231 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the chlordiazepoxide hydrochloride and clidinium bromide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CHLORDIAZEPOXIDE-CLIDINIUM CAP?
The current National Average Drug Acquisition Cost (NADAC) for CHLORDIAZEPOXIDE-CLIDINIUM CAP, manufactured by Amneal Pharmaceuticals NY LLC, is $0.2545 per EA (NDC 60219167701), effective Aug 19, 2026.
How has the price of CHLORDIAZEPOXIDE-CLIDINIUM CAP changed over time?
Over the history we have for it, the NADAC for CHLORDIAZEPOXIDE-CLIDINIUM CAP has declined 73.5%. It has been tracked across 231 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for CHLORDIAZEPOXIDE-CLIDINIUM CAP?
Since Mar 23, 2022, the NADAC for CHLORDIAZEPOXIDE-CLIDINIUM CAP has ranged from a low of $0.2088 (Apr 19, 2023) to a high of $0.9594 (Apr 13, 2022), with a median of $0.3254 per EA.
Are there cheaper alternatives to CHLORDIAZEPOXIDE-CLIDINIUM CAP?
No other NADAC-published product currently shares the active ingredient and strength of CHLORDIAZEPOXIDE-CLIDINIUM CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CHLORDIAZEPOXIDE-CLIDINIUM CAP?
CHLORDIAZEPOXIDE-CLIDINIUM CAP (NDC 60219167701) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.